Dara Biosciences (DARA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access DARA Annual Balance Sheets →
The balance sheet data below highlights changes in Dara Biosciences's financial position over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2015)
(Jun 30 2015) (Mar 31 2015) (Dec 31 2014) (Sep 30 2014)
Assets
Cash & cash equivalent4.66
Cash & Short-term Investments4.00
Accounts receivable1.15
Other Receivables0.00
Inventories0.27
Prepaid Expense And Other Assets Current0.15
Total Current Assets6.22
Equipment/Property/Plant Net0.03
Goodwill net0.82
Intangible Assets2.60
Long-term investments0.01
Total Assets9.68
Liabilities
Accounts Payable, Current AC0.89
Accrued Liabilities, Current1.08
Capital Lease Obligations, Current LO0.01
Deferred Revenue DE0.32
Total Current Liabilities3.44
Capital Lease Obligations, Noncurrent LO0.02
Total Long-term Debt0.02
Deferred Rent Credit, Noncurrent DE0.06
Total Liabilities3.51
Stockholders' Equity
Preferred Stock Series B Value0.00
Common Stock Value0.20
Additional Paid In Capital Common Stock80.50
Retained Earnings / Accumulated Deficit-74.53
Common Stockholder's Equity6.17
Non-controlling interests & other0.00
Total Stockholder's Equity6.17
Liabilities & Stockholder's Equity9.68
4 historic quarters locked

Sign in to unlock the full Dara Biosciences balance sheet history.

About DARA Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.